TSO3 (TOS) Sets New 12-Month Low at $0.30

TSO3 Inc. (TSE:TOS)’s share price reached a new 52-week low on Tuesday . The company traded as low as C$0.30 and last traded at C$0.31, with a volume of 147591 shares. The stock had previously closed at C$0.33.

A number of equities analysts have weighed in on the stock. Desjardins restated a “hold” rating on shares of TSO3 in a research report on Sunday, March 31st. Echelon Wealth Partners restated a “buy” rating on shares of TSO3 in a research report on Wednesday, January 9th.

The company has a current ratio of 8.22, a quick ratio of 6.52 and a debt-to-equity ratio of 894.59. The stock has a market capitalization of $29.90 million and a price-to-earnings ratio of -2.18.

TSO3 (TSE:TOS) last posted its quarterly earnings data on Wednesday, March 27th. The company reported C($0.04) earnings per share for the quarter, topping the Zacks’ consensus estimate of C($0.05) by C$0.01. The company had revenue of C$1.48 million for the quarter. On average, research analysts forecast that TSO3 Inc. will post -0.0709859192922041 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This piece was published by Community Financial News and is the sole property of of Community Financial News. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright law. The correct version of this piece can be accessed at https://www.com-unik.info/2019/04/25/tso3-tos-sets-new-12-month-low-at-0-30.html.

TSO3 Company Profile (TSE:TOS)

TSO3 Inc engages in the research, development, production, maintenance, sale, and licensing of sterilization processes, related consumable supplies, and accessories for heat and moisture sensitive medical devices worldwide. Its principal product is the STERIZONE VP4 sterilizer, a dual sterilant, low temperature sterilization system that utilizes vaporized hydrogen peroxide and ozone that is marketed in Canada and the United States.

Recommended Story: Price-Sales Ratio

Receive News & Ratings for TSO3 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TSO3 and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit